ArticleCancer research2026

KRAS Inhibitor-Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

Mona Tomaschko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.